Choline deficiency associated with total parenteral nutrition

Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.

Neuro-degenerative diseases·2008

Low intracerebroventricular doses of cholinotoxin AF64A do not affect the morphology of gonadotropin hormone-releasing hormone (GnRH)-immunoreactive fibers in the rat septum.

Brain research·2005

Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.

Brain research·2004

Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats.

Neurobiology of aging·2003

Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.

Neurobiology of aging·2002

Toxicity and pharmacokinetics of isolated lung perfusion with cisplatin in rat.

The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi·2001

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Application of the "oral simulated tube feeding method" in enteral nutrition for patients with moderately severe acute pancreatitis: a randomized controlled non-inferiority trial comparing the nasogastric feeding route.

Frontiers in nutrition·2026

Association of Malnutrition, Inflammation, and Residual Kidney Clearance in Peritoneal Dialysis: A Cross-Sectional Analysis.

International journal of nephrology·2026

Genetic sequencing of children with malrotation and midgut volvulus: A cross-sectional study.

JPGN reports·2026

Advancements in research on feeding intolerance to enteral nutrition in neurocritical patients undergoing sedation and analgesia.

Frontiers in nutrition·2026

[Changing trends of nutritional status among children and adolescents aged 6-18 in Zhejiang Province from 2005 to 2024].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026

Optimizing teduglutide treatment regimens in children with short bowel syndrome.

Frontiers in pediatrics·2026

Related Experiment Videos

Choline deficiency associated with total parenteral nutrition

Related Concept Videos

Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.

Low intracerebroventricular doses of cholinotoxin AF64A do not affect the morphology of gonadotropin hormone-releasing hormone (GnRH)-immunoreactive fibers in the rat septum.

Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.

Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats.

Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.

Toxicity and pharmacokinetics of isolated lung perfusion with cisplatin in rat.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Application of the "oral simulated tube feeding method" in enteral nutrition for patients with moderately severe acute pancreatitis: a randomized controlled non-inferiority trial comparing the nasogastric feeding route.

Association of Malnutrition, Inflammation, and Residual Kidney Clearance in Peritoneal Dialysis: A Cross-Sectional Analysis.

Genetic sequencing of children with malrotation and midgut volvulus: A cross-sectional study.

Advancements in research on feeding intolerance to enteral nutrition in neurocritical patients undergoing sedation and analgesia.

[Changing trends of nutritional status among children and adolescents aged 6-18 in Zhejiang Province from 2005 to 2024].

Optimizing teduglutide treatment regimens in children with short bowel syndrome.

Related Experiment Videos

Choline deficiency associated with total parenteral nutrition

Related Concept Videos

Related Articles